Molecular Control of Brown Adipose Cell Fate and Energy Metabolism

棕色脂肪细胞命运和能量代谢的分子控制

基本信息

  • 批准号:
    10094152
  • 负责人:
  • 金额:
    $ 49.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

Uncoupling Protein 1 (UCP1) is a mitochondrial protein specific to thermogenic adipocytes (brown and beige fat) that uncouples cellular respiration and mitochondrial ATP synthesis to dissipate energy in the form of heat. Because UCP1 has been considered the sole thermogenic protein responsible for non-shivering thermogenesis in the adipose tissue, the prevailing dogma is that the action of UCP1 primarily mediates the functions of brown and beige fat, which promote the anti-obesity and anti-diabetic effects when activated. However, our data from the previous funding cycle and other labs suggest an incongruity in the metabolic phenotypes between brown/beige fat-deficiency and UCP1-deficiency: we found that beige fat-deficient mice, caused by the fat-specific deletion of PRDM16 or its co-factor EHMT1, develop obesity and glucose intolerance even under ambient temperature, whereas UCP1 knockout mice are not diabetic and develop obesity only under thermoneutrality. This discrepancy motivated us to search for UCP1-independent mechanisms in the regulation of energy homeostasis. We recently identified a non-canonical (UCP1-independent) thermogenic mechanism that may explain the above quandary. UCP1-independent thermogenesis involves ATP-dependent Ca2+ cycling through Sarco/endoplasmic reticulum Ca2+-ATPase2b (SERCA2b) and Ryanodine Receptor 2 (RyR2) in beige fat. Ca2+ cycling thermogenesis is activated, in part, through α1-AR signaling in response to a cold stimulus, and requires active glucose oxidation. Thereby beige fat functions as a “glucose sink” and improves systemic glucose tolerance. Notably, Ca2+ cycling thermogenesis is an evolutionally conserved mechanism in humans, mice, and also in pigs, a rare mammalian species that lacks a functional UCP1 protein. Accordingly, the current proposal aims to determine the biological significance and the mechanisms pertinent to this non-canonical thermogenesis in beige fat.
解偶联蛋白 1 (UCP1) 是一种产热脂肪细胞(棕色和米色脂肪)特有的线粒体蛋白,可解偶联细胞呼吸和线粒体 ATP 合成,以热量形式耗散能量。由于 UCP1 被认为是负责脂肪组织中非颤抖产热的唯一产热蛋白,因此普遍认为 UCP1 的作用主要介导棕色和米色脂肪的功能,激活后可促进抗肥胖和抗糖尿病作用。然而,我们从上一个资助周期和其他实验室获得的数据表明,棕色/米色脂肪缺乏症和 UCP1 缺乏症之间的代谢表型不一致:我们发现,由 PRDM16 或其辅助因子 EHMT1 的脂肪特异性缺失引起的米色脂肪缺乏症小鼠,即使在环境温度下也会出现肥胖和葡萄糖不耐受,而 UCP1 敲除小鼠也会出现肥胖和葡萄糖不耐症。 小鼠没有糖尿病,只有在热中性的情况下才会出现肥胖。这种差异促使我们寻找独立于 UCP1 的能量稳态调节机制。我们最近发现了一种非规范的(独立于 UCP1 的)生热机制,可以解释上述困境。 UCP1 独立的生热作用涉及 ATP 依赖性 Ca2+ 通过肌节/内质网 Ca2+-ATPase2b (SERCA2b) 和米色脂肪中 Ryanodine 受体 2 (RyR2) 的循环。 Ca2+ 循环生热作用部分是通过响应冷刺激的 α1-AR 信号传导而被激活的,并且需要主动的葡萄糖氧化。因此,米色脂肪起到“葡萄糖汇”的作用,并改善全身葡萄糖耐量。值得注意的是,Ca2+ 循环生热作用是人类、小鼠以及猪(一种缺乏功能性 UCP1 蛋白的稀有哺乳动物)中进化上保守的机制。因此,当前的提案旨在确定与米色脂肪中这种非典型生热作用相关的生物学意义和机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shingo Kajimura其他文献

Shingo Kajimura的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shingo Kajimura', 18)}}的其他基金

Post-translational control of adipose tissue remodeling and metabolic health
脂肪组织重塑和代谢健康的翻译后控制
  • 批准号:
    10264160
  • 财政年份:
    2020
  • 资助金额:
    $ 49.56万
  • 项目类别:
Mitochondrial metabolite compartmentalization in health and disease
健康和疾病中的线粒体代谢物区室化
  • 批准号:
    10226352
  • 财政年份:
    2020
  • 资助金额:
    $ 49.56万
  • 项目类别:
Mitochondrial metabolite compartmentalization in health and disease
健康和疾病中的线粒体代谢物区室化
  • 批准号:
    10643941
  • 财政年份:
    2020
  • 资助金额:
    $ 49.56万
  • 项目类别:
Mitochondrial metabolite compartmentalization in health and disease
健康和疾病中的线粒体代谢物区室化
  • 批准号:
    10064156
  • 财政年份:
    2020
  • 资助金额:
    $ 49.56万
  • 项目类别:
Molecular control of beige fat heterogeneity
米色脂肪异质性的分子控制
  • 批准号:
    10220026
  • 财政年份:
    2020
  • 资助金额:
    $ 49.56万
  • 项目类别:
Mitochondrial metabolite compartmentalization in health and disease
健康和疾病中的线粒体代谢物区室化
  • 批准号:
    10435518
  • 财政年份:
    2020
  • 资助金额:
    $ 49.56万
  • 项目类别:
Post-translational control of adipose tissue remodeling and metabolic health
脂肪组织重塑和代谢健康的翻译后控制
  • 批准号:
    10453585
  • 财政年份:
    2020
  • 资助金额:
    $ 49.56万
  • 项目类别:
Molecular control of beige fat heterogeneity
米色脂肪异质性的分子控制
  • 批准号:
    10645161
  • 财政年份:
    2020
  • 资助金额:
    $ 49.56万
  • 项目类别:
Molecular control of beige fat heterogeneity
米色脂肪异质性的分子控制
  • 批准号:
    10026279
  • 财政年份:
    2020
  • 资助金额:
    $ 49.56万
  • 项目类别:
Mitochondrial BCAA transporter in physiology and disease
生理学和疾病中的线粒体支链氨基酸转运蛋白
  • 批准号:
    10318672
  • 财政年份:
    2020
  • 资助金额:
    $ 49.56万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 49.56万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.56万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 49.56万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.56万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 49.56万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.56万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 49.56万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 49.56万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 49.56万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.56万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了